O
CELG

OppenheimerFunds’s Celgene Corp CELG Stock Holding History

OppenheimerFunds’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.45M Sell
15,349
-1,459,699
-99% -$128M ﹤0.01% 950
2018
Q4 		$94.5M Sell
1,475,048
-71,858
-5% -$5.3M 0.13% 152
2018
Q3 		$138M Sell
1,546,906
-283,973
-16% -$25.1M 0.16% 152
2018
Q2 		$145M Sell
1,830,879
-1,233,315
-40% -$102M 0.17% 143
2018
Q1 		$273M Sell
3,064,194
-728,425
-19% -$69.9M 0.34% 76
2017
Q4 		$396M Buy
3,792,619
+301,838
+9% +$34.1M 0.48% 48
2017
Q3 		$509M Sell
3,490,781
-519,430
-13% -$70.8M 0.63% 27
2017
Q2 		$521M Buy
4,010,211
+204,649
+5% +$25.1M 0.64% 24
2017
Q1 		$474M Buy
3,805,562
+1,490,625
+64% +$178M 0.57% 31
2016
Q4 		$268M Sell
2,314,937
-14,533
-0.6% -$1.62M 0.34% 83
2016
Q3 		$244M Buy
2,329,470
+1,351,007
+138% +$146M 0.31% 86
2016
Q2 		$96.5M Sell
978,463
-90,300
-8% -$9.34M 0.13% 193
2016
Q1 		$107M Buy
1,068,763
+317,876
+42% +$32.7M 0.14% 176
2015
Q4 		$89.9M Sell
750,887
-358,308
-32% -$41.5M 0.11% 194
2015
Q3 		$120M Sell
1,109,195
-750,435
-40% -$93.1M 0.16% 158
2015
Q2 		$215M Sell
1,859,630
-4,700
-0.3% -$537K 0.25% 112
2015
Q1 		$215M Sell
1,864,330
-9,880
-0.5% -$1.18M 0.24% 116
2014
Q4 		$210M Sell
1,874,210
-199,570
-10% -$21M 0.23% 124
2014
Q3 		$197M Buy
2,073,780
+282,260
+16% +$25.5M 0.22% 134
2014
Q2 		$154M Buy
1,791,520
+9,880
+0.6% +$751K 0.17% 155
2014
Q1 		$124M Sell
1,781,640
-168,820
-9% -$13.4M 0.15% 172
2013
Q4 		$165M Buy
1,950,460
+154,800
+9% +$12.2M 0.2% 140
2013
Q3 		$138M Buy
1,795,660
+501,340
+39% +$35.1M 0.18% 143
2013
Q2 		$75.7M Buy
+1,294,320
New +$77.9M 0.11% 236

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OppenheimerFunds's CELG Position: Q1 2019 in Review

OppenheimerFunds reduced its Celgene Corp (CELG) stake by 99% in Q1 2019, selling an estimated $128M and leaving 15,349 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #950.

OppenheimerFunds first reported a position in CELG in Q2 2013 and has held it in 24 quarters since. The position peaked at $521M in Q2 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • OppenheimerFunds held 15,349 shares of Celgene Corp worth $1.45M as of Q1 2019.
  • OppenheimerFunds sold 1,459,699 Celgene Corp shares in Q1 2019, an estimated $128M.
  • Celgene Corp made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #950 holding.
  • OppenheimerFunds first reported a position in Celgene Corp in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Celgene Corp position peaked at $521M in Q2 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.